We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBRG
1001
DELISTED
TruBridge
TBRG
$422K ﹤0.01%
15,301
-366
-2% -$9.65K
INMD icon
1002
InMode
INMD
$871M
$419K ﹤0.01%
+23,204
New +$381K
VIV icon
1003
Telefônica Brasil
VIV
$18.7B
$419K ﹤0.01%
54,757
+21,988
+67% +$199K
SHOE
1004
Shoe Station Group
SHOE
$426M
$416K ﹤0.01%
+24,828
New +$375K
FPI
1005
Farmland Partners
FPI
$428M
$415K ﹤0.01%
+62,233
New +$423K
ALSN icon
1006
Allison Transmission
ALSN
$10.4B
$414K ﹤0.01%
11,808
+6,271
+113% +$227K
JCI icon
1007
Johnson Controls International
JCI
$93.2B
$414K ﹤0.01%
+10,123
New +$396K
RDY icon
1008
Dr. Reddy's Laboratories
RDY
$10.4B
$414K ﹤0.01%
+29,775
New +$355K
UAL icon
1009
United Airlines
UAL
$40.8B
$414K ﹤0.01%
+11,887
New +$411K
MSGS icon
1010
Madison Square Garden
MSGS
$9.51B
$406K ﹤0.01%
+2,698
New +$423K
PHI icon
1011
PLDT
PHI
$4.25B
$405K ﹤0.01%
15,000
+5,985
+66% +$167K
QURE icon
1012
uniQure
QURE
$3.13B
$401K ﹤0.01%
10,877
-261,297
-96% -$10.7M
USB icon
1013
US Bancorp
USB
$100B
$400K ﹤0.01%
+11,148
New +$408K
UROV
1014
DELISTED
Urovant Sciences Ltd.
UROV
$397K ﹤0.01%
42,546
+27,001
+174% +$240K
ATRS
1015
DELISTED
Antares Pharma, Inc.
ATRS
$396K ﹤0.01%
147,025
-118,782
-45% -$329K
WAFD icon
1016
WaFd
WAFD
$2.8B
$395K ﹤0.01%
18,960
-19,173
-50% -$452K
TTM
1017
DELISTED
Tata Motors Limited
TTM
$394K ﹤0.01%
+43,371
New +$361K
TTEK icon
1018
Tetra Tech
TTEK
$9.09B
$392K ﹤0.01%
+20,525
New +$365K
AB icon
1019
AllianceBernstein
AB
$3.48B
$389K ﹤0.01%
+14,393
New +$403K
ROK icon
1020
Rockwell Automation
ROK
$49.4B
$389K ﹤0.01%
1,760
-9,863
-85% -$2.2M
IX icon
1021
ORIX
IX
$43.3B
$385K ﹤0.01%
+30,825
New +$379K
TVRD
1022
Tvardi Therapeutics
TVRD
$22.6M
$384K ﹤0.01%
838
-1,242
-60% -$721K
EPR icon
1023
EPR Properties
EPR
$4.57B
$380K ﹤0.01%
+13,848
New +$433K
HCSG icon
1024
Healthcare Services Group
HCSG
$1.46B
$380K ﹤0.01%
17,617
-122,750
-87% -$2.86M
ANDE icon
1025
Andersons Inc
ANDE
$2.23B
$378K ﹤0.01%
+19,729
New +$325K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.